ProPhase Labs, Inc. (PRPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1244766,
    "name": "ProPhase Labs, Inc.",
    "stock_name": "ProPhase Labs, Inc.",
    "full_name": "ProPhase Labs, Inc.",
    "name_url": "stocks-analysis/prophase-labs-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.14",
    "chg": 0,
    "chgp": "-0.71%",
    "dir": -1,
    "prev_price": "0.14",
    "mcapval": "20.71",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2310,
    "indexname": "S&P 500",
    "isin": "US74345W1080",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "594.97 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prophase-labs-inc-1244766-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is ProPhase Labs, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prophase-labs-inc-technically-bullish-or-bearish-3545496",
        "imagepath": "",
        "date": "2025-09-20 19:12:57",
        "description": "As of 10 September 2025, the technical trend for ProPhase Labs, Inc. has changed from sideways to mildly bullish. The weekly and monthly MACD indicators are both mildly bullish, while the monthly RSI is bullish. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands show a mixed signal with a mildly bullish weekly and a mildly bearish monthly. The KST is mildly bearish weekly and bearish monthly, while the Dow Theory indicates a mildly bullish monthly trend. Overall, the technical stance is mildly bullish, driven primarily by the MACD and monthly RSI.\n\nIn terms of performance, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -44.83% compared to the S&P 500's 12.22%, and a one-year return of -82.95% versus 17.14% for the index...."
      },
      {
        "title": "Is ProPhase Labs, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-prophase-labs-inc-overvalued-or-undervalued-3542202",
        "imagepath": "",
        "date": "2025-09-20 17:47:20",
        "description": "As of 10 August 2023, the valuation grade for ProPhase Labs, Inc. has moved from expensive to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued, particularly given its negative P/E ratio and troubling returns on capital, with a ROCE of -119.77% and an ROE of -149.07%. The Price to Book Value stands at 1.25, while the EV to Sales ratio is notably high at 2.53, suggesting that investors are paying a premium despite the company's losses.\n\nIn comparison to its peers, ProPhase Labs, Inc. has a less favorable valuation profile, with Chromadex Corp. showing a P/E of 39.82 and EV to EBITDA of 36.56, indicating a more robust market position. Similarly, LifeVantage Corp. is valued more attractively with a P/E of 14.81 and EV to EBITDA of 8.26. The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -44.83% comp..."
      }
    ],
    "total": 7,
    "sid": "1244766",
    "stock_news_url": "https://www.marketsmojo.com/news/prophase-labs-inc-1244766"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is ProPhase Labs, Inc. technically bullish or bearish?

2025-09-20 19:12:57

As of 10 September 2025, the technical trend for ProPhase Labs, Inc. has changed from sideways to mildly bullish. The weekly and monthly MACD indicators are both mildly bullish, while the monthly RSI is bullish. However, the daily moving averages indicate a mildly bearish stance. The Bollinger Bands show a mixed signal with a mildly bullish weekly and a mildly bearish monthly. The KST is mildly bearish weekly and bearish monthly, while the Dow Theory indicates a mildly bullish monthly trend. Overall, the technical stance is mildly bullish, driven primarily by the MACD and monthly RSI. In terms of performance, the stock has underperformed significantly against the S&P 500 across multiple periods, with a year-to-date return of -44.83% compared to the S&P 500's 12.22%, and a one-year return of -82.95% versus 17.14% for the index....

Is ProPhase Labs, Inc. overvalued or undervalued?

2025-09-20 17:47:20

As of 10 August 2023, the valuation grade for ProPhase Labs, Inc. has moved from expensive to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued, particularly given its negative P/E ratio and troubling returns on capital, with a ROCE of -119.77% and an ROE of -149.07%. The Price to Book Value stands at 1.25, while the EV to Sales ratio is notably high at 2.53, suggesting that investors are paying a premium despite the company's losses. In comparison to its peers, ProPhase Labs, Inc. has a less favorable valuation profile, with Chromadex Corp. showing a P/E of 39.82 and EV to EBITDA of 36.56, indicating a more robust market position. Similarly, LifeVantage Corp. is valued more attractively with a P/E of 14.81 and EV to EBITDA of 8.26. The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -44.83% comp...

View All News